Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicole M Kuderer

Showing results (1-10 of 87) with videos related to

Pageof 9
Sort By:
Oncology (Williston Park, N.Y.)|February 4, 2010
CYP2D6 testing in breast cancer: ready for prime time?Nicole M Kuderer, Jeffrey Peppercorn
Thrombosis Research|August 2, 2020
Clinical practice guidelines for the treatment and prevention of cancer-associated thrombosisGary H Lyman, Nicole M Kuderer
Supportive Cancer Therapy|July 17, 2008
Epidemiology of febrile neutropeniaGary H Lyman, Nicole M Kuderer
Clinical Breast Cancer|January 24, 2007
Gene expression profile assays as predictors of recurrence-free survival in early-stage breast cancer: a metaanalysisGary H Lyman, Nicole M Kuderer
Current Hematology Reports|October 17, 2003
Cost effectiveness of myeloid growth factors in cancer chemotherapyGary H Lyman, Nicole M Kuderer
BMC Medical Research Methodology|April 27, 2005
The strengths and limitations of meta-analyses based on aggregate dataGary H Lyman, Nicole M Kuderer
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 17, 2012
Comparative effectiveness research, genomics-enabled personalized medicine, and rapid learning health care: a common bondGeoffrey S Ginsburg, Nicole M Kuderer
Drugs|December 14, 2002
Filgrastim in patients with neutropenia: potential effects on quality of lifeGary H Lyman, Nicole M Kuderer
Supportive Cancer Therapy|July 17, 2008
A primer in prognostic and predictive models: development and validation of neutropenia risk modelsGary H Lyman, Nicole M Kuderer
Thrombosis Research|May 28, 2014
Guidelines for treatment and prevention of venous thromboembolism among patients with cancerNicole M Kuderer, Gary H Lyman
Pageof 9

Showing results (1-10 of 87) with videos related to

Sort By:
Pageof 9
Oncology (Williston Park, N.Y.)|February 4, 2010
CYP2D6 testing in breast cancer: ready for prime time?Nicole M Kuderer, Jeffrey Peppercorn
Thrombosis Research|August 2, 2020
Clinical practice guidelines for the treatment and prevention of cancer-associated thrombosisGary H Lyman, Nicole M Kuderer
Supportive Cancer Therapy|July 17, 2008
Epidemiology of febrile neutropeniaGary H Lyman, Nicole M Kuderer
Clinical Breast Cancer|January 24, 2007
Gene expression profile assays as predictors of recurrence-free survival in early-stage breast cancer: a metaanalysisGary H Lyman, Nicole M Kuderer
Current Hematology Reports|October 17, 2003
Cost effectiveness of myeloid growth factors in cancer chemotherapyGary H Lyman, Nicole M Kuderer
BMC Medical Research Methodology|April 27, 2005
The strengths and limitations of meta-analyses based on aggregate dataGary H Lyman, Nicole M Kuderer
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 17, 2012
Comparative effectiveness research, genomics-enabled personalized medicine, and rapid learning health care: a common bondGeoffrey S Ginsburg, Nicole M Kuderer
Drugs|December 14, 2002
Filgrastim in patients with neutropenia: potential effects on quality of lifeGary H Lyman, Nicole M Kuderer
Supportive Cancer Therapy|July 17, 2008
A primer in prognostic and predictive models: development and validation of neutropenia risk modelsGary H Lyman, Nicole M Kuderer
Thrombosis Research|May 28, 2014
Guidelines for treatment and prevention of venous thromboembolism among patients with cancerNicole M Kuderer, Gary H Lyman
Pageof 9